Historical award
Osivax
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (12 days old).
Fiscal year 2026: data through (12 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $743,969.31
- Potential award value
- $743,969.31
- Total obligated to date
- $743,969.31
Source date: Nov 9, 2026
Recorded work
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
Award activity
- Obligations in covered fiscal years
- $743,969.31
- Transactions in covered fiscal years
- 3
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75A50125C00006_7505_-NONE-_-NONE-